LEQEMBI® [ (lecanemab-irmb) 100 mg/mL injection for intravenous use] is indicated for the treatment of Alzheimer’s disease (AD). Treatment with LEQEMBI should be initiated in patients with mild ...
NDAB Creativity // Shutterstock The latest longevity trend? Social wellness clubs. On a Monday afternoon at Othership in New York City, 60 people gather in a room armed with bathi ...